These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2761484)

  • 1. [Potential risk of pharmacologically induced hypochlorhydria in the treatment of peptic ulcer disease].
    Ljubicić N; Rotkvić I
    Med Pregl; 1989; 42(1-2):65-8. PubMed ID: 2761484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential hazards of hypochlorhydria in the treatment of peptic ulcer.
    Axon AT
    Scand J Gastroenterol Suppl; 1986; 122():17-21. PubMed ID: 3535017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of gastric acid secretion and therapeutic results: is there any correlation?
    Corinaldesi R; Ghidini C; Ricci Maccarini M; Santaguida P; Fratesi E; Barbara G; Stanghellini V
    Ital J Gastroenterol; 1990; 22 Suppl 1():2-4. PubMed ID: 1983421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH, healing rate and symptom relief in acid-related diseases.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1996; 69(2):159-74. PubMed ID: 9112748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acid-peptic diseases by inhibition of gastric H+,K+-ATPase.
    McArthur KE; Jensen RT; Gardner JD
    Annu Rev Med; 1986; 37():97-105. PubMed ID: 3010811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori and its involvement in gastritis and peptic ulcer formation.
    Konturek SJ; Konturek PC; Konturek JW; Plonka M; Czesnikiewicz-Guzik M; Brzozowski T; Bielanski W
    J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():29-50. PubMed ID: 17033104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gastropulmonary route of infection--fact or fiction?
    Tryba M
    Am J Med; 1991 Aug; 91(2A):135S-146S. PubMed ID: 1909096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in intragastric nitrite and vitamin C levels during acid inhibitory therapy.
    Mowat C; McColl KE
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):523-37. PubMed ID: 11403544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptic ulcers can now be cured without operation.
    Baron JH
    Ann R Coll Surg Engl; 1995 May; 77(3):168-73. PubMed ID: 7598412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptic ulcer--current status.
    Brooks FP
    Clin Invest Med; 1987 May; 10(3):108-16. PubMed ID: 3113795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intestinal infections due to inhibition of gastric acid secretion in reflux disease].
    Otten MH
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2511-4. PubMed ID: 10627752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intriguing relationship of Helicobacter pylori infection and acid secretion in peptic ulcer disease and gastric cancer.
    Malfertheiner P
    Dig Dis; 2011; 29(5):459-64. PubMed ID: 22095010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
    Wagstaff AJ; Benfield P; Monk JP
    Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Will anti-ulcer drugs soon differ only in their side effects?].
    Miederer SE
    Fortschr Med; 1986 Dec; 104(3):918-20. PubMed ID: 2881864
    [No Abstract]   [Full Text] [Related]  

  • 16. [Appraisal of therapeutic agents for peptic ulcer by continuous intragastric pH monitoring].
    Saeki S; Tomofuji Y; Yasuda T; Mitooka H; Onoyama Y; Baba S
    Rinsho Byori; 1984 Oct; 32(10):1076-83. PubMed ID: 6549190
    [No Abstract]   [Full Text] [Related]  

  • 17. Future treatment of peptic ulcers.
    Calam J
    Scand J Gastroenterol Suppl; 1985; 117():47-53. PubMed ID: 2869578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antisecretory effect of losec and pariet in peptic ulcer therapy].
    Nemytin IuV; Makarov IuS; Pavlov AI; Kashchenko OI; Lezhenina NP; Golochalova TV
    Voen Med Zh; 2002 Oct; 323(10):44-6. PubMed ID: 12479006
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of NSAID-associated peptic ulcer disease.
    Melcarne L; García-Iglesias P; Calvet X
    Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):723-33. PubMed ID: 26775657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intragastric bacterial overgrowth--a possible risk in the long-term treatment of peptic ulcer disease. Round table conference, XIIth International Congress of Gastroenterology, Lisbon, 21 September, 1984.
    Scand J Gastroenterol Suppl; 1985; 111():1-51. PubMed ID: 3859908
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.